212 related articles for article (PubMed ID: 2192902)
1. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density.
Hehmke B; Lucke S; Schröder D; Klöting I; Kohnert KD
Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902
[TBL] [Abstract][Full Text] [Related]
2. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats.
Hehmke B; Schröder D; Klöting I
Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210
[TBL] [Abstract][Full Text] [Related]
3. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors.
Hehmke B; Schröder D; Klöting I; Kohnert KD
J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761
[TBL] [Abstract][Full Text] [Related]
4. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
[TBL] [Abstract][Full Text] [Related]
5. Complement-dependent antibody mediated cytotoxicity (C'AMC) in patients with newly diagnosed insulin-dependent diabetes mellitus.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Exp Clin Endocrinol; 1987 Aug; 89(3):375-82. PubMed ID: 3666052
[TBL] [Abstract][Full Text] [Related]
6. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats.
Schröder D; Hehmke B; Klöting I; Schmidt S
Diabetes Res; 1991 Jun; 17(2):81-91. PubMed ID: 1817815
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
8. Effect of syngeneic islet antigen administration on complement-dependent antibody-mediated cytotoxicity to islet cells and diabetes onset in diabetes-prone BB/OK rats.
Schröder D; Schmidt S; Klöting I; Hehmke B
Autoimmunity; 1993; 14(4):283-9. PubMed ID: 8347771
[TBL] [Abstract][Full Text] [Related]
9. Prospective investigations of long-term normoglycaemic BB/OK-rats: serial determination of glucose tolerance, insulitis, B-cell volume density and pancreatic insulin content.
Hahn HJ; Lucke S; Klöting I; Besch W
Exp Clin Endocrinol; 1991; 98(3):185-92. PubMed ID: 1778238
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
Knospe S; Köhler E; Klöting I
Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study.
Ziegler B; Klöting I; Besch W; Ziegler M; Hahn HJ
Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954
[TBL] [Abstract][Full Text] [Related]
12. Humoral-mediated cytotoxicity to rat pancreatic exocrine cells in serum of diabetes-prone BB/OK rats--predictive value for diabetes onset.
Schröder D; Hehmke B; Klöting I; Schmidt S
Diabetes Res; 1993; 23(3):105-13. PubMed ID: 7712684
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains.
Schlosser M; Ziegler B; Augstein P; Klöting I; Ziegler M
Diabetes Res; 1994; 26(2):67-77. PubMed ID: 7554727
[TBL] [Abstract][Full Text] [Related]
14. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release.
Sadovnikova NV; Pankov YA; Fedotov VP; Czernushkina AV; Zhukovsky MA; Shcherbacheva LN
Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810
[TBL] [Abstract][Full Text] [Related]
15. Effects of transforming growth factor beta (TGF-beta) on the lymphocyte- and cytokine-mediated destruction of islet cells in the BB/Wor rat.
Koevary SB
Lymphokine Cytokine Res; 1991 Oct; 10(5):337-42. PubMed ID: 1768735
[TBL] [Abstract][Full Text] [Related]
16. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions.
Schröder D; Hehmke B; Klöting I; Besch W
Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813
[TBL] [Abstract][Full Text] [Related]
17. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
Klöting N; Follak N; Klöting I
Physiol Genomics; 2005 Dec; 24(1):59-64. PubMed ID: 16189279
[TBL] [Abstract][Full Text] [Related]
18. Effects of incubation of islet cells with transforming growth factor beta (TGF-beta) on their susceptibility to diabetic lymphocyte mediated destruction in the rat, in vitro.
Koevary SB
Diabetes Res; 1991 Nov; 18(3):123-7. PubMed ID: 1841822
[TBL] [Abstract][Full Text] [Related]
19. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis.
Marner B; Lernmark A; Ludvigsson J; MacKay P; Matsuba I; Nerup J; Rabinovitch A
Diabetes Res; 1985 Sep; 2(5):231-6. PubMed ID: 3905187
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
